AzTrials
AzTrials

Depression Anxiety DisorderNCT06820814

The Association Between Physical Symptoms and Depression Among Medical Students in Egypt

An observational study of Depression Anxiety Disorder and Physical Disorders, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To examine the association between depression and physical symptoms among medical students in Egypt. Read more about this study

Who is it for?
Ages 19 to 24 years
How many people
155 participants
Where
1 siteEgypt
Study dates
8 Feb 2025to 20 Feb 2025
How long will I take part?
1 Week
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 24 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: Medical students enrolled in any medical program in Egypt.

Who may be able to join

  • Medical students enrolled in any medical program in Egypt.
  • Age range: Typically 19 to 30 years (or based on your study's demographic focus).
  • Willingness to participate and provide informed consent.
  • Self-reported symptoms of depression: Those who indicate moderate to severe symptoms on screening tools (e.g., PHQ-9).
  • Physical symptoms: Those who report experiencing physical symptoms (e.g., headaches, fatigue, gastrointestinal discomfort, etc.) on a checklist.

Who cannot join

  • Non-medical students (students outside of the medical program).
  • Students with a history of major medical conditions that may confound the physical symptoms (e.g., chronic diseases like diabetes, hypertension, or neurological disorders).
  • Students with a diagnosed psychiatric disorder (e.g., bipolar disorder, schizophrenia, etc.) or those already undergoing psychiatric treatment.
  • Non-consenting individuals: Students who decline to participate in the study or do not provide informed consent.
  • Incomplete responses: Students who fail to provide adequate or valid responses in the questionnaires.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo University

    Cairo, Giza Governorate

Other trials in Egypt

About this study

To examine the association between depression and physical symptoms among medical students in Egypt.

Read the detailed description

The Google Form will be open for one week from the start of the academic term. It is divided into three parts:

Demographic Data - which includes age, academic level, relationship status, and whether the student intends to work while studying.

Patient Health Questionnaire PHQ-9: Assesses symptoms of poor mental health in the two weeks prior to the start of term.

Patient Health Questionnaire PHQ-15: This is a measure of physical symptoms felt in the week prior to the commencement of the academic term.

The questionnaire will be distributed among different medical faculties in Egypt and all students will be required to fill it out. Data analysis will be done through SPSS to explore the relationship between psychological and physical symptoms.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PATIENT HEALTH QUESTIONNAIRE (PHQ-9)

    The Patient Health Questionnaire-9 (PHQ-9) used for screening, diagnosing, monitoring, and measuring the severity of depression.

    It consists of nine questions; Each item is scored from 0 (Not at all) to 3 (Nearly every day), leading to a total score ranging from 0 to 27.

    Scores can be categorized as follows:

    1-4: Minimal or no depression 5-9: Mild depression 10-14: Moderate depression 15-19: Moderately severe depression 20-27: Severe depression

    Measured: 1 week

  2. PATIENT HEALTH QUESTIONNAIRE PHYSICAL SYMPTOMS (PHQ-15)

    PATIENT HEALTH QUESTIONNAIRE PHYSICAL SYMPTOMS (PHQ-15) used to assess the severity of somatic (physical) symptoms.

    Consists of 15 common physical symptoms (e.g., stomach pain, dizziness, fatigue).

    Each symptom is rated based on how much it has bothered the individual in the past 7 days.

    Scoring system:

    0 = Not bothered at all

    1. = Bothered a little
    2. = Bothered a lot Total score range: 0 to 30 Minimal: 0-4 Low: 5-9 Medium: 10-14 High: 15-30

    Measured: 1 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Feb 2025
  2. Study start8 Feb 2025
  3. Primary completion15 Feb 2025
  4. Study completion20 Feb 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
155 participants (actual)
Target duration
1 Week
IDs, dates and publications
ClinicalTrials.gov ID
NCT06820814
Sponsor's protocol ID
Not Yet
Status last verified
Feb 2025
First submitted
6 Feb 2025
Last updated
24 Feb 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Depression Anxiety Disorder and Physical Disorders, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PATIENT HEALTH QUESTIONNAIRE (PHQ-9) (time frame: 1 week). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in